Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals

NCT01575873 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01575873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01575873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
March 28, 2012
Completion date
June 29, 2017
Enrollment
795 (actual)
Sites
99

Conditions

As the registry lists them; a condition with its own page is linked.

steroid-induced osteopor, glucocorticoid-induced ostepor